These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 6187017)

  • 21. Effect of anti-pilus antibodies on survival of gonococci within guinea pig subcutaneous chambers.
    Lambden PR; Heckels JE; Watt PJ
    Infect Immun; 1982 Oct; 38(1):27-30. PubMed ID: 6128301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of epitopes recognized by monoclonal antibodies SM1 and SM2 which react with all pili of Neisseria gonorrhoeae but which differentiate between two structural classes of pili expressed by Neisseria meningitidis and the distribution of their encoding sequences in the genomes of Neisseria spp.
    Virji M; Heckels JE; Potts WJ; Hart CA; Saunders JR
    J Gen Microbiol; 1989 Dec; 135(12):3239-51. PubMed ID: 2483993
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Common heat stable protective antigen in gonococci.
    Ito JI; Corbeil LB; Wunderlich AC; McCutchan JA; Braude AI
    Trans Assoc Am Physicians; 1979; 92():160-8. PubMed ID: 95067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Strategies for mimicking Neisserial saccharide epitopes as vaccines.
    Gulati S; Ngampasutadol J; Yamasaki R; McQuillen DP; Rice PA
    Int Rev Immunol; 2001; 20(2):229-50. PubMed ID: 11878767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Gonococcal surface antigens and their significance for serotyping and vaccines].
    Kohl PK; Meyer TF; Petzoldt D
    Hautarzt; 1985 Jun; 36(6):320-5. PubMed ID: 2862130
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gonococcal pilus vaccine. Studies of antigenicity and inhibition of attachment.
    Tramont EC; Sadoff JC; Boslego JW; Ciak J; McChesney D; Brinton CC; Wood S; Takafuji E
    J Clin Invest; 1981 Oct; 68(4):881-8. PubMed ID: 6116723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Strain-specific and common epitopes of gonococcal pili.
    Rothbard JB; Fernandez R; Schoolnik GK
    J Exp Med; 1984 Jul; 160(1):208-21. PubMed ID: 6203999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The sixth C. L. Oakley lecture. Molecular studies on the pathogenesis of gonorrhoea.
    Heckels JE
    J Med Microbiol; 1984 Dec; 18(3):293-307. PubMed ID: 6209398
    [No Abstract]   [Full Text] [Related]  

  • 29. Gonococcal vaccine studies in Inuvik.
    Greenberg L; Diena BB; Ashton FA; Wallace R; Kenny CP; Znamirowski R; Ferrari H; Atkinson J
    Can J Public Health; 1974; 65(1):29-33. PubMed ID: 4205640
    [No Abstract]   [Full Text] [Related]  

  • 30. [Some aspects of the study of gonorrhea vaccine].
    He F; Zhao L
    Zhonghua Yu Fang Yi Xue Za Zhi; 1998 Jul; 32(4):248-50. PubMed ID: 10322765
    [No Abstract]   [Full Text] [Related]  

  • 31. Preliminary studies on the development of a gonococcal vaccine.
    Greenberg I; Diena BB; Kenny CP; Znamirowski R
    Bull World Health Organ; 1971; 45(4):531-5. PubMed ID: 5004708
    [No Abstract]   [Full Text] [Related]  

  • 32. Neisseria gonorrhoeae vaccine development: hope on the horizon?
    Edwards JL; Jennings MP; Seib KL
    Curr Opin Infect Dis; 2018 Jun; 31(3):246-250. PubMed ID: 29601324
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Protective properties of gonococcal vaccines].
    Ovchinnikov NM; Timchenko GF
    Vestn Dermatol Venerol; 1976 Dec; (12):28-32. PubMed ID: 828819
    [No Abstract]   [Full Text] [Related]  

  • 34. Contribution of interactions between complement inhibitor C4b-binding protein and pathogens to their ability to establish infection with particular emphasis on Neisseria gonorrhoeae.
    Blom AM; Ram S
    Vaccine; 2008 Dec; 26 Suppl 8():I49-55. PubMed ID: 19388165
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design and immune characterization of a novel Neisseria gonorrhoeae DNA vaccine using bacterial ghosts as vector and adjuvant.
    Jiao H; Yang H; Zhao D; Chen J; Zhang Q; Liang J; Yin Y; Kong G; Li G
    Vaccine; 2018 Jul; 36(30):4532-4539. PubMed ID: 29914847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pyrogenal-vaccine therapy of men with gonorrhea].
    Shamshin NF; Malykh VA
    Vestn Dermatol Venerol; 1980 Nov; (11):62-4. PubMed ID: 6778014
    [No Abstract]   [Full Text] [Related]  

  • 37. Some perspectives on the problem of gonorrhea.
    Weiler PG; Maddox DE
    J Ky Med Assoc; 1977 Jan; 75(1):16-20, 49. PubMed ID: 401857
    [No Abstract]   [Full Text] [Related]  

  • 38. [Ways and prospects of producing gonococcal vaccine].
    Bednova VN; Dmitriev GA; Pasternak NI
    Vestn Dermatol Venerol; 1987; (11):41-7. PubMed ID: 3125694
    [No Abstract]   [Full Text] [Related]  

  • 39. Development of a gonorrhoea vaccine: prospects, strategies and tactics.
    Gotschlich EC
    Bull World Health Organ; 1984; 62(5):671-80. PubMed ID: 6150769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of a gonococcal cell-wall lectin-adhesin with vaccine potential.
    Perrollet H; Guinet RM
    Ann Sclavo Collana Monogr; 1986; 3(1-2):399-406. PubMed ID: 3122804
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.